SHENYANG, China, Sept. 15 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the results of the shareholder votes at its 2008 Annual General Meeting of Shareholders held on September 12, 2008 (Friday) at 10:00 a.m. (Beijing time).
At the meeting, the Company's shareholders re-elected Dr. Jing Lou, Liping Xu, Bin Huang, Lawrence S. Wizel, Mingde Yu and Moujia Qi to serve as members of the Board of Directors until the next annual meeting of shareholders to take place in 2009. They also approved the appointment of KPMG to serve as the Company's independent registered public accountants for the year ending December 31, 2008.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .
Contacts:
Investor Contact: Investor Relations (US):
Kevin Teo, CFO Mahmoud Siddig
3SBio Inc. Taylor Rafferty
+86 24 2581 1820 +1 (212) 889-4350
Investor Relations (HK): Media Contact:
Ruby Yim Jason Marshall
Taylor Rafferty Taylor Rafferty
+852 3196 3712 +1 (212) 889-4350
